Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: A single-institute analysis of 742 patients

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 1, 2012, Pages 191-199

  Cozzarini, Cesare ^a   Fiorino, Claudio ^a   Da Pozzo, Luigi Filippo ^a   Alongi, Filippo ^a   Berardi, Genoveffa ^a   Bolognesi, Angelo ^a   Briganti, Alberto ^a   Broggi, Sara ^a   Deli, Aniko ^a   Guazzoni, Giorgio ^a   Perna, Lucia ^a   Pasetti, Marcella ^a   Salvadori, Giovannella ^a   Montorsi, Francesco ^a   Rigatti, Patrizio ^a   Di Muzio, Nadia ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Adjuvant; Prostate cancer; Radiotherapy; Salvage; Urinary toxicity

Indexed keywords

ACUTE TOXICITY; ADJUVANT; COVARIATES; HYPERTENSIVE PATIENTS; MEDIAN RADIATION; MULTI VARIATE ANALYSIS; POSTOPERATIVE RADIOTHERAPY; PROSTATE CANCERS; PROSTATE CARCINOMA; RADIATION DOSE; UNIVARIATE ANALYSIS; WHOLE-PELVIS RADIOTHERAPY;

DISEASES; DOSIMETRY; MULTIVARIANT ANALYSIS; SALVAGING; TOXICITY;

RADIOTHERAPY;

ADULT; AGE; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BLADDER BLEEDING; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; COHORT ANALYSIS; FOLLOW UP; HUMAN; HYPERTENSION; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PELVIS; POSTOPERATIVE CARE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; RADIATION DOSE; RADIATION INJURY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; URETHRA STRICTURE; URINARY TRACT DISEASE; URINE INCONTINENCE;

AGED; ANALYSIS OF VARIANCE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; RISK; ROC CURVE; SALVAGE THERAPY; SENSITIVITY AND SPECIFICITY; URETHRAL STRICTURE; URINARY BLADDER; URINARY INCONTINENCE;

EID: 83955162977     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.09.027     Document Type: Article

References (38)

1. M. Bolla, H. Van Poppel, and L. Collette Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911) Lancet 366 2005 572 578
2. I.M.J. Thompson, C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial JAMA 296 2006 2329 2335
3. T. Wiegel, D. Bottke, and U. Steiner Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 2009 2924 2930
4. M.S. Katz, M.J. Zelefsky, and E.S. Venkatraman Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer J Clin Oncol 21 2003 483 489
5. A.J. Stephenson, S.F. Shariat, and M.J. Zelefsky Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy JAMA 291 2004 1325 1332
6. T.H. van der Kwast, M. Bolla, and H. Van Poppel Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911 J Clin Oncol 25 2007 4178 4186
7. M.J. Zelefsky, E.J. Levin, and M. Hunt Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 2008 1124 1129
8. R. Choo, M. Pearse, and C. Danjoux Analysis of gastrointestinal and genitourinary morbidity of postoperative radiotherapy for pathologic T3 disease or positive surgical margins after radical prostatectomy using National Cancer Institute Expanded Common Toxicity Criteria Int J Radiat Oncol Biol Phys 72 2008 989 995
9. A. Harsolia, C. Vargas, and D. Yan Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: Dose-volume analysis of a phase II dose-escalation study Int J Radiat Oncol Biol Phys 69 2007 1100 1109
10. M.R. Cheung, S.L. Tucker, and L. Dong Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 67 2007 1059 1065
11. C. Cozzarini, C. Fiorino, and G.L. Ceresoli Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy) Int J Radiat Oncol Biol Phys 55 2003 688 694
12. A. Trotti, A.D. Colevas, and A. Setser CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181
13. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
14. P. Dunn-Rankin, and F. Wilcoxon The true distributions of the range of rank totals in the two-way classification Psychometrika 31 1966 573 580
15. D.R. Cox Regression models and life tables J R Stat Soc 34 1982 187 220
16. C. Cozzarini, F. Montorsi, and C. Fiorino Need for high radiation dose (>70 Gy) in early postoperative irradiation after radical prostatectomy: A single-institution analysis of 334 high-risk, node-negative patients Int J Radiat Oncol Biol Phys 75 2009 966 974
17. D.M. Carnell, R.E. Smith, and F.M. Daley An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: Implications for radioresistance Int J Radiat Oncol Biol Phys 65 2006 91 99
18. C.R. King, and D.S. Kapp Radiotherapy after prostatectomy: Is the evidence for dose escalation out there? Int J Radiat Oncol Biol Phys 71 2008 346 350
19. J.R.J. Bernard, S.J. Buskirk, and M.G. Heckman Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: Dose-response analysis Int J Radiat Oncol Biol Phys 76 2009 735 740
20. R. Cheung, S.L. Tucker, and J.S. Ye Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 58 2004 1513 1519
21. B.G. Gardner, A.L. Zietman, and W.U. Shipley Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer J Urol 167 2002 123 126
22. P.J. Eifel, C. Levenback, and J.T. Wharton Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix Int J Radiat Oncol Biol Phys 32 1995 1289 1300
23. S.J. Feigenberg, A.L. Hanlon, and E.M. Horwitz Long-term androgen deprivation increases grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapy Int J Radiat Oncol Biol Phys 62 2005 397 405
24. M.J. Zelefsky, D. Cowen, and Z. Fuks Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma Cancer 85 1999 2460 2468
25. T.E. Schultheiss, W.R. Lee, and M.A. Hunt Late GI and GU complications in the treatment of prostate cancer Int J Radiat Oncol Biol Phys 37 1997 3 11
26. M. Liu, T. Pickles, and A. Agranovich Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy Int J Radiat Oncol Biol Phys 58 2004 59 67
27. B.A. Jereczek-Fossa, D. Zerini, and C. Fodor Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapy Int J Radiat Oncol Biol Phys 78 2010 26 34
28. L. Sullivan, S.G. Williams, and K.H. Tai Urethral stricture following high dose rate brachytherapy for prostate cancer Radiother Oncol 91 2009 232 236
29. P.G. Borboroglu, J.P. Sands, and J.L. Roberts Risk factors for vesicourethral anastomotic stricture after radical prostatectomy Urology 56 2000 96 100
30. D.M. Herold, A.L. Hanlon, and G.E. Hanks Diabetes mellitus: A predictor for late radiation morbidity Int J Radiat Oncol Biol Phys 43 1999 475 479
31. S.H. Giordano, A. Lee, and Y.F. Kuo Late gastrointestinal toxicity after radiation for prostate cancer Cancer 107 2006 423 432
32. D. Taussky, K. Bae, and J.P. Bahary Does timing of androgen deprivation influence radiation-induced toxicity? A secondary analysis of Radiation Therapy Oncology Group protocol 9413 Urology 72 2008 1125 1129
33. A.B. Jani, S.D. Parikh, and S. Vijayakumar Analysis of influence of age on acute and chronic radiotherapy toxicity in treatment of prostate cancer Urology 65 2005 1157 1162
34. L.W. Toy How much do we understand about the effects of ageing on healing? J Wound Care 14 2005 472 476
35. A. Crooks How does ageing affect the wound healing process? J Wound Care 14 2005 222 223
36. C. Fiorino, R. Valdagni, and T. Rancati Dose-volume effects for normal tissues in external radiotherapy: Pelvis Radiother Oncol 93 2009 153 167
37. M. Feng, A.L. Hanlon, and T.M. Pisansky Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy Int J Radiat Oncol Biol Phys 68 2007 1417 1423
38. B. Jereczek-Fossa, D. Zerini, and A. Vavassori Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy Int J Radiat Oncol Biol Phys 74 2009 115 125